Press Releases

Cervical Cancer Market is Forecasted to Hit US$ 16.2 Bn By 2031 | CAGR 9.6%

The Global Cervical Cancer Market, encompassing pharmaceuticals, medical devices, and diagnostic solutions, is witnessing remarkable growth driven by

  • Date: 09 Apr, 2024
  • Author: Sagar Karlekar
Acute Kidney Injury (AKI) Market is Forecasted to Hit US$ 1,929.5 Mn By 2031 | CAGR 9.7%

The Global Acute Kidney Injury (AKI) Market, a crucial segment of the pharmaceutical industry, is poised for substantial growth in the coming years. A

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Amyotrophic Lateral Sclerosis (ALS) Market is Forecasted to Hit US$ 1,330.9 Mn By 2031 | CAGR 9.8%

The Global Amyotrophic Lateral Sclerosis (ALS) Market is expected to reach US$ 1,330.9 million by 2031, exhibiting a remarkable growth rate of 9.8% du

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
PD-1 Resistant Head and Neck Cancer (HNC) Market Expected to Achieve US$ 1,928.6 Million by 2031 | CAGR 41.5%

The PD-1 Resistant Head and Neck Cancer (HNC) Market is a part of the pharmaceutical industry, focused on developing novel therapies for patients with

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Alport Syndrome Market is Forecasted to Hit US$ 1,313.9 Mn By 2031 | CAGR 11.5%

The Alport Syndrome Market Expected to Achieve US$ 1,313.9 Mn by 2031, growing at a robust CAGR of 11.5% during the forecast period of 2024-2031.

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Powered Surgical Instrument Market Expected to Achieve US$ 7.5 Bn by 2031 | CAGR 11.2%

The Global Powered Surgical Instrument Market, part of the broader medical devices industry, is witnessing significant growth driven by technological

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Solid Tumor Therapeutics Market is Forecasted to Hit US$ 302.8 Bn By 2031 | CAGR 10.2%

The Solid Tumor Therapeutics Market Expected to Achieve US$ 302.8 Bn by 2031 exhibiting a robust CAGR 10.2% during the forecast period from

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Molecular Weight Marker Market is Forecasted to Hit US$ 2.5 Bn By 2031 | CAGR 7.2%

The Global Molecular Weight Marker Market is expected to reach US$ 2.5 Bn in 2031, with a growth rate of 9.8%. Molecular weight markers are essential

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Small Molecule Drug Discovery Market is Forecasted to Hit US$ 68.1 Bn By 2031 | CAGR 8.6%

The Small Molecule Drug Discovery Market is a crucial segment of the pharmaceutical industry, focused on the research, development, and commercializat

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Local and Dental Anesthesia Drugs Market is Forecasted to Hit US$ 7.2 Bn By 2031 | CAGR 6.9%

The Global Local and Dental Anesthesia Drugs Market is a critical segment of the pharmaceutical industry, encompassing a wide range of products design

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Anti-retroviral Drug Market is Forecasted to Hit US$ 45.1 Bn By 2031 | CAGR 5.9%

The Anti-retroviral drug market falls under the pharmaceutical industry and is dedicated to the development, manufacturing, and distribution of medica

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Urinary Tract Infection Treatment Market is Forecasted to Hit US$ 11.3 Bn By 2031 | CAGR 7.8%

The global Urinary Tract Infection Treatment Market is a rapidly growing segment within the pharmaceutical industry, driven by the increasing prevalen

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Patient Registry Software Market is Forecasted to Hit US$ 4.4 Bn By 2031 | CAGR 17.5%

The global Patient Registry Software Market is expected to reach US$ 4.4 Bn in 2031, growing at a compound annual growth rate (CAGR) of 17.5% during t

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Hairy Cell Leukemia Market is Forecasted to Hit US$ 506.8 Mn By 2031 | CAGR 8.7%

Hairy Cell Leukemia Market Expected to Achieve US$ 506.8 Mn by 2031 with a growing CAGR 8.7%. Hairy Cell Leukemia Market is a niche segment withi

  • Date: 03 Apr, 2024
  • Author: Sagar Karlekar
Nasopharyngeal Cancer Market is Forecasted to Hit US$ 2.5 Bn By 2031 | CAGR 7.2%

The Global Nasopharyngeal Cancer Market is a rapidly evolving sector within the pharmaceutical industry, dedicated to developing innovative treatments

  • Date: 01 Apr, 2024
  • Author: Sagar Karlekar